Perceptive Advisors LLC Verona Pharma PLC Transaction History

Perceptive Advisors LLC

$44.8 Billion
Q3 2025

A detailed history of Perceptive Advisors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Perceptive Advisors LLC holds 524,088 shares of VRNA stock, worth $56 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

524,088

Previous 5,507,591 90.48%

Holding current value

$56 Million

Previous $521 Million 89.27%

% of portfolio

0.12%

Previous 22.87%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$90.08 - $106.69 $449 Million - $532 Million	-4,983,503 Reduced 90.48%	524,088 $55.9 Million
Q2 2025 Aug 14, 2025	SELL	$53.9 - $98.68 $56.9 Million - $104 Million	-1,055,749 Reduced 16.09%	5,507,591 $521 Million
Q1 2025 May 15, 2025	BUY	$44.81 - $69.63 $7.67 Million - $11.9 Million	171,234 Added 2.68%	6,563,340 $417 Million
Q4 2024 Feb 14, 2025	BUY	$28.71 - $47.02 $2.19 Million - $3.58 Million	76,173 Added 1.21%	6,392,106 $297 Million
Q3 2024 Nov 14, 2024	BUY	$15.46 - $30.16 $60 Million - $117 Million	3,882,208 Added 159.52%	6,315,933 $182 Million

Q2 2024 Aug 14, 2024	SELL	$11.48 - $17.02 $15.2 Million - $22.6 Million	-1,327,851 Reduced 35.3%	2,433,725 $35.2 Million
Q1 2024 May 15, 2024	SELL	$15.3 - $20.24 $1.6 Million - $2.12 Million	-104,638 Reduced 2.71%	3,761,576 $60.5 Million
Q4 2023 Feb 14, 2024	SELL	$11.94 - $20.47 $1.68 Million - $2.89 Million	-140,983 Reduced 3.52%	3,866,214 $76.9 Million
Q3 2023 Nov 14, 2023	SELL	$16.3 - $22.09 $6.36 Million - $8.61 Million	-389,919 Reduced 8.87%	4,007,197 $65.3 Million
Q2 2023 Aug 14, 2023	BUY	$19.41 - $23.43 $32.3 Million - $39 Million	1,663,326 Added 60.84%	4,397,116 $93 Million
Q1 2023 May 15, 2023	SELL	$18.06 - $25.27 $38.8 Million - $54.3 Million	-2,146,929 Reduced 43.99%	2,733,790 $54.9 Million
Q4 2022 Feb 14, 2023	SELL	$9.84 - $26.13 $1.64 Million - $4.35 Million	-166,545 Reduced 3.3%	4,880,719 $128 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $8.83 Million - $29 Million	2,132,118 Added 73.14%	5,047,264 $51.6 Million
Q2 2022 Aug 15, 2022	SELL	$3.55 - $5.06 $458,507 - $653,534	-129,157 Reduced 4.24%	2,915,146 $12.2 Million
Q1 2022 May 16, 2022	BUY	$4.82 - $6.98 $852,142 - $1.23 Million	176,793 Added 6.17%	3,044,303 $15.2 Million
Q4 2021 Feb 14, 2022	SELL	$3.91 - $7.08 $83,591 - $151,363	-21,379 Reduced 0.74%	2,867,510 $19.3 Million
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $12.9 Million - $29.5 Million	2,888,889 New	2,888,889 $18 Million
Q3 2018 Nov 14, 2018	SELL	$11.65 - $14.1 $260,109 - $314,810	-22,327 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.66 - $21.0 $462,268 - $710,661	-33,841 Reduced 60.25%	22,327 $307,000
Q1 2018 May 15, 2018	SELL	$11.69 - $20.97 $1.68 Million - $3.02 Million	-143,832 Reduced 71.92%	56,168 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$11.96 - $16.95 $2.39 Million - $3.39 Million	200,000	200,000 $3.07 Million

Others Institutions Holding VRNA

# of Institutions

273

Shares Held

76.9M

Call Options Held

686K

Put Options Held

442K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $6.52B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Verona Pharma PLC Transaction History